Vitiligo in a Patient Receiving Adalimumab for Idiopathic Uveitis
In recent years, adalimumab has been increasingly used in the chronic treatment of non-infectious uveitis. This case report aimed to describe a drug-induced adverse event in a 34-year-old man who presented with blurred vision and floaters in the right eye and was being treated for intermediate uveit...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Turkish Ophthalmology Society
2024-04-01
|
| Seri Bilgileri: | Türk Oftalmoloji Dergisi |
| Konular: | |
| Online Erişim: |
http://www.oftalmoloji.org/archives/archive-detail/article-preview/vitiligo-in-a-patient-receiving-adalimumab-for-dio/64992
|
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|